• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Bachem Holding AG

+ Add to Watchlist


39.678 EUR 0.159 0.40%

As of 11:08:57 ET on 11/27/2014.

Snapshot for Bachem Holding AG (BHM)

Open: 40.255 Day's Range: 39.173 - 40.255 Volume: 0
Previous Close: 39.519 52wk Range: 35.735 - 42.051 1-Yr Rtn: +6.27%

Stock Chart for BHM

No chart data available.
  • BHM:GR 39.678
  • 1D
  • 1M
  • 1Y
Interactive BHM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BHM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 23.6369
Relative P/E vs. DAX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) 2.0180
Est. PEG Ratio -
Market Cap (M EUR) 540.20
Shares Outstanding (M) 6.80
30 Day Average Volume 16
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.61%
Cash Dividend (CHF) 1.7500
Dividend Ex-Date 04/30/2014
5 Year Dividend Growth -7.60%
Next Earnings Announcement 03/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BHM

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for BHM

Bachem Holding AG manufactures ingredients for pharmaceuticals, generic drugs, and research supplies. The Company produces peptides and amino-acids for medications and laboratory research, and prescription medicines that are no longer patent protected. Bachem sells its products to universities, and pharmaceutical and biotechnology companies.

Thomas FruehChairman-Mgmt Board/CEOStephan SchindlerCFO-Member Mgmt Board
Daniel ErneCTO-Member Mgmt BoardJose De ChastonayCMO-Member Mgmt Board
More Company Profile & Key Executives for BHM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil